Probing the resolution of 2-phenylpropanoyl chloride using quasi-enantiomeric Evans’ oxazolidinones
摘要:
The parallel kinetic resolution of 2-phenylpropanoyl chloride using quasi-enantiomeric oxazolidinones is discussed. The levels of diastereoselectivity were found to be dependent on the presence of an additional (quasi)-enantiomeric oxazolidinone and its structural nature. The origin of this stereocontrol was believed to be due to hetero-aggregation between (quasi)-enantiomeric oxazolidinone components. (C) 2004 Elsevier Ltd. All rights reserved.
[EN] HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS<br/>[FR] COMPOSES HETEROCYCLIQUES POUR LE TRAITEMENT DES TROUBLES DU SYSTEME NERVEUX CENTRAL ET DES TROUBLES CARDIOVASCULAIRES
申请人:THE UPJOHN COMPANY
公开号:WO1995018118A1
公开(公告)日:1995-07-06
(EN) Novel aromatic bicyclic amines of formula (I) are useful in treating central nervous system disorders and cardiac arrhythmias and cardiac fibrillation.(FR) L'invention concerne de nouvelles amines bicycliques aromatiques de formule (I) destinées à être utilisées pour le traitement des troubles du système nerveux central, des arythmies cardiaques et de la fibrillation cardiaque.
(中) 公式(I)的新型芳香族双环胺在治疗中枢神经系统疾病、心律失常和心房颤动方面具有用途。
HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS
申请人:THE UPJOHN COMPANY
公开号:EP0737189A1
公开(公告)日:1996-10-16
US5877317A
申请人:——
公开号:US5877317A
公开(公告)日:1999-03-02
US6133446A
申请人:——
公开号:US6133446A
公开(公告)日:2000-10-17
Heterocyclic compounds for the treatment of CNS and cardiovascular
申请人:Pharmacia & Upjohn Company
公开号:US05877317A1
公开(公告)日:1999-03-02
Novel aromatic bicyclic amines of formula (I) ##STR1## are useful in treating central nervous system disorders and cardiac arrhythmias and cardiac fibrillation.